# Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931

> **NCT01284595** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C] AZD8931

## Key facts

- **NCT ID:** NCT01284595
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284595, "Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01284595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*